Holo raises €1 million to bring personalised lab testing and daily-life health tracking to more users

Barcelona-based Holo has closed a €1 million pre-Seed funding round to transform how people understand and manage their health through an all-in-one app that combines advanced lab testing, AI, and functional medicine, integrated with devices such as Apple Watch, Garmin, and Oura.

The round was led by Calm/Storm Ventures and Mission VC, with participation from ENISA and a group of business angels and early customers of the company, including Javier López and Emilio Nicolás (Magnific AI, Freepik), Carlos Villanueva (Google), Álex Rodríguez (MarsBased), Álvaro López (Polygon Labs), Samuel Fernández and Sergi Molins (Factorial), José de Cabo (Olapic, Remotely Works), Esteve Almirall (Node Living), and Luis Sanz (Carto).

“Health should be something we understand – not something we ignore until something goes wrong. At Holo, we want everyone to have control over their well-being as easily as they manage their finances. We want to create the Revolut of health,” explains Francesc Navarro, CEO and co-founder.

In 2025, several European startups in preventive health, diagnostics, and longevity announced new funding in similar verticals.

Switzerland’s Aeon secured €8.2 million to scale its AI-driven preventive-health platform combining whole-body MRI, biomarkers and genetics, while Bulgaria’s Blue Longevity Clinic raised €2 million to expand its longevity-medicine clinics across Southeast Europe. Sweden’s Epigenica collected €1.8 million to advance high-throughput epigenetic screening tools, and Germany’s Skleo Health closed a €3 million Seed round to scale its AI-powered preventive eye-screening platform. Lithuania’s MELP added €1.25 million to grow its employee well-being and longevity-focused platform in the UK.

Collectively, these rounds account for approximately €16.25 million in sector-relevant funding.

In this context, Holo’s pre-Seed round sits within a growing wave of European startup funding focused on preventive health, diagnostics, longevity and consumer-oriented health platforms.

While Holo is relatively early-stage and at a smaller ticket size compared to some of the peers listed above, its Barcelona base adds to the geographic diversity of the space. Notably none of the comparable companies listed here are Spanish-based, so Holo adds national representation in Spain’s ecosystem.

The presence of larger rounds indicates investor interest in the preventive health category, and Holo’s focus on wearables integration + lab biomarkers + functional medicine aligns well with the broader shift described in the market toward proactive health monitoring rather than reactive care.

“In the coming years, everyone will have a complete profile of their health in their pocket. That information won’t just prevent disease – it will help people live better every day. Holo will be the platform that makes it possible,” says Emilio Rodríguez, co-founder and Chief Product Officer.

Founded in 2024 by Francesc Navarro, Emilio Rodríguez, and Sergio Mosquera, all former members of fellow Barceloba-based unicorn Factorial.

Holo was born from a simple but powerful idea: health doesn’t start in a hospital, it starts in daily life. The platform enables users to take comprehensive lab tests at leading laboratories, connect wearables, and receive personalised medical reports reviewed by doctors specialised in prevention and longevity.

Each user receives a dynamic map of their health, with more than 110 biomarkers analysing everything from inflammation and hormones to longevity. This holistic view allows users to anticipate risks before symptoms appear and optimize energy and well-being in daily life.

“The combination of science, technology, and user experience can transform the way we live. Our purpose is to create a new standard in prevention and well-being,” adds Sergio Mosquera, CTO and co-founder.

With this pre-seed round, Holo will strengthen its position in Spain and prepare for its European expansion in 2026. Funds will go toward product development, new medical integrations, and clinical collaborations across Europe.

In Spain, the company already works closely with Laboratorios Echevarne. Holo is also developing new complementary services and personalised longevity programmes, reinforcing its vision to become the leading platform for preventive health in Europe.

“From our very first meeting, we were impressed by the team’s executional excellence and product and engineering expertise gained during their time scaling Factorial, one of Europe’s leading tech unicorns. With Holo, they’re applying that same discipline and speed to the fast-growing preventive-health and longevity space – a market driven by rising consumer demand and still underserved in Europe,” shares Lucanus Polagnoli, General Partner at Calm/Storm Ventures.

The post Holo raises €1 million to bring personalised lab testing and daily-life health tracking to more users appeared first on EU-Startups.